title: A change in treatment from etanercept to infliximab was effective to control scleritis in a patient with rheumatoid arthritis.
authors.forename: Yukio
authors.initials: Y
authors.lastname: Sassa
authors.forename: Yo-Ichi
authors.initials: Y
authors.lastname: Kawano
authors.forename: Toshiko
authors.initials: T
authors.lastname: Yamana
authors.forename: Tatsuoki
authors.initials: T
authors.lastname: Mashima
authors.forename: Tatsuro
authors.initials: T
authors.lastname: Ishibashi
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D057915:Drug Substitution; D004359:Drug Therapy, Combination; D000068800:Etanercept; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D000069285:Infliximab; D008727:Methotrexate / Q000627:therapeutic use; D011239:Prednisolone / Q000008:administration & dosage; D018124:Receptors, Tumor Necrosis Factor; D015423:Scleritis / Q000139:chemically induced / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D005938:Glucocorticoids; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D011239:Prednisolone; D000069285:Infliximab; D000068800:Etanercept; D008727:Methotrexate